These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 21534237

  • 21. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR, Romero B, Fernandez-Carbonero E, Sánchez-Casado E, Cubero JJ.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [Abstract] [Full Text] [Related]

  • 22. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S.
    Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
    [Abstract] [Full Text] [Related]

  • 23. [New concept of chronic kidney disease and blockade of renin-angiotensin system].
    Takeda T, Gejyo F.
    Nihon Rinsho; 2007 Sep; 65(9):1727-33. PubMed ID: 17877002
    [Abstract] [Full Text] [Related]

  • 24. Renal protection with angiotensin receptor blockers: where do we stand.
    Schmieder RE, Ruilope LM, Barnett AH.
    J Nephrol; 2011 Sep; 24(5):569-80. PubMed ID: 21404225
    [Abstract] [Full Text] [Related]

  • 25. Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions.
    Tylicki L, Lizakowski S, Rutkowski B.
    J Nephrol; 2012 Sep; 25(6):900-10. PubMed ID: 22684647
    [Abstract] [Full Text] [Related]

  • 26. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
    Cohen DL, Townsend RR.
    J Am Soc Nephrol; 2009 Aug; 20(8):1666-8. PubMed ID: 18776118
    [Abstract] [Full Text] [Related]

  • 27. [Renin inhibition and the kidney].
    Ecder T.
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [Abstract] [Full Text] [Related]

  • 28. [Management of hypertension in CKD patients].
    Kusaba T, Kimura K.
    Nihon Rinsho; 2008 Sep; 66(9):1747-52. PubMed ID: 18788405
    [Abstract] [Full Text] [Related]

  • 29. Enhanced Angiotensin II type 1 receptor expression in leukocytes of patients with chronic kidney disease.
    Chon H, Neumann J, Boer P, Joles JA, Braam B.
    Eur J Pharmacol; 2011 Sep; 666(1-3):205-10. PubMed ID: 21640098
    [Abstract] [Full Text] [Related]

  • 30. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F, Rangoonwala B.
    Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
    [Abstract] [Full Text] [Related]

  • 32. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB, Coffman TM.
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [Abstract] [Full Text] [Related]

  • 33. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [Abstract] [Full Text] [Related]

  • 34. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
    Ahmed AK, Kamath NS, El Kossi M, El Nahas AM.
    Nephrol Dial Transplant; 2010 Dec; 25(12):3977-82. PubMed ID: 19820248
    [Abstract] [Full Text] [Related]

  • 35. Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.
    Doulton TW, MacGregor GA.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):185-9. PubMed ID: 19617273
    [Abstract] [Full Text] [Related]

  • 36. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M, Franchini M, Fanos V.
    Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial.
    Maione A, Nicolucci A, Craig JC, Tognoni G, Moschetta A, Palasciano G, Pugliese G, Procaccini DA, Gesualdo L, Pellegrini F, Strippoli GF, LIRICO study group.
    J Nephrol; 2007 Jan; 20(6):646-55. PubMed ID: 18046666
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.